Change in Liver Function in Durvalumab Plus Tremelimumab Treatment for Unresectable Hepatocellular Carcinoma. Tamaki N, Mori N, Takaki S, Tsuji K, et al. Anticancer Res 2024;44:3913-3918.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tamaki N, Mori N, Takaki S, Tsuji K, et al. Change in Liver Function in Durvalumab Plus Tremelimumab Treatment for Unresectable Hepatocellular Carcinoma. Anticancer Res 2024;44:3913-3918.
PMID: 39197893